Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche Might Buy Illumina, Echo Therapeutics Prices Public Offering: Healthcare Business Wrap
Wall Street Cheat Street
Saturday, December 22, 2012 - 1:04pm
tags:
Roche, Illumina, Echo Therapeutics, M&A
Teva Pharmaceutical Industries Limited : Back in Fashion : High-Grade Corporate Bonds
4-Traders
Saturday, December 22, 2012 - 1:01pm
tags:
Teva Pharmaceuticals
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
NASDAQ
Saturday, December 22, 2012 - 1:00pm
tags:
procysbi, Raptor Pharmaceuticals, nephropathic cystinosis
Cubist Submits ENTEREG Supplemental NDA
Pipeline Review
Saturday, December 22, 2012 - 12:58pm
tags:
Cubist Pharmaceuticals, Entereg, GI recovery
9 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, December 22, 2012 - 12:56pm
tags:
Corcept Therapeutics, Cornerstone Therapeutics, Bristol-Myers Squibb, ViroPharma, MAP Pharmaceuticals, Hi-Tech Pharmacal, GSK, Hospira, Teva Pharmaceuticals
Transcept caps a tough year with PhII drug failure
Fierce Biotech
Saturday, December 22, 2012 - 12:54pm
tags:
Transcept, TO-2061, OCD
2 Winners From the Medical Robot Apocalypse
Motley Fool
Saturday, December 22, 2012 - 12:40pm
tags:
robotics, Intuitive Surgical, Mako Surgical, devices
Will This Pharmaceutical Rise in 2013?
m
Saturday, December 22, 2012 - 12:39pm
tags:
Eli Lilly
AcelRx Pharma: Pain Drug Developer With A Pair Of Q1 2013 Phase III Catalysts
Seeking Alpha
Saturday, December 22, 2012 - 12:38pm
tags:
pain management, AcelRx, Sufentanil NanoTab PCA System
Why Berkshire Soured on Johnson & Johnson
Motley Fool
Saturday, December 22, 2012 - 12:36pm
tags:
JNJ
GlaxoSmithKline Wins FDA Approval for Flu Vaccine
Motley Fool
Saturday, December 22, 2012 - 12:30pm
tags:
Fluarix, flu vaccines, vaccines
Alexza's agitation drug gets FDA approval
Reuters
Saturday, December 22, 2012 - 12:29pm
tags:
Alexza, Adasuve, schizophrenia, bipolar disorder
Myriad Alleviates to Outperform
Yahoo/Zacks
Saturday, December 22, 2012 - 12:28pm
tags:
Myriad Genetics
Why Vical Will Keep Plunging
Motley Fool
Saturday, December 22, 2012 - 12:27pm
tags:
Vical
Does Qsymia Have a Future After All?
Wall Street Cheat Street
Saturday, December 22, 2012 - 12:26pm
tags:
Qsymia, weight loss, obesity, Vivus
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, December 22, 2012 - 12:25pm
tags:
Oncothyreon, Amicus Therapeutics, Herbalife
Why Cerus Is Poised to Plunge
Motley Fool
Saturday, December 22, 2012 - 12:24pm
tags:
Cerus
Upcoming FDA Decision For AVEO's Tivozanib Builds Speculation
Seeking Alpha
Saturday, December 22, 2012 - 12:23pm
tags:
Aveo Pharmaceutical, tivozanib, ONYX Pharmaceuticals
4 Investing Lessons From Questcor's 2012
Motley Fool
Saturday, December 22, 2012 - 12:22pm
tags:
Questcor Pharmaceuticals
Buy Galena Biopharma Now
Seeking Alpha
Saturday, December 22, 2012 - 12:21pm
tags:
Galena Biopharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.